Early valve replacement for people with severe but silent aortic narrowing
Part of Heart & circulation clinical trials.
This trial tests whether replacing a badly narrowed aortic valve earlier—even when you feel fine—can prevent future heart problems. It compares early valve replacement (through a catheter or surgery) versus standard watchful waiting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic valve narrowing based on heart scan measurements (valve area, blood speed, and heart-team review)
- Your symptoms are considered absent (“asymptomatic”) by a cardiology specialist
- You are considered a candidate for valve replacement using either catheter (TAVR) or surgery (AVR)
- Your heart scan or blood test shows early strain or stress signs (such as higher filling pressure, weaker heart squeeze, or abnormal lab results)
- You are 18 to 85 years old and can sign informed consent
- You do NOT have certain exclusions like weak pumping (low LVEF), very severe narrowing, major other valve disease, past valve surgery, kidney failure, dementia, possible pregnancy, or a type of narrowing outside the valve
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This study looks at whether replacing a narrowed heart valve early helps people who have severe aortic stenosis but no symptoms. You would be randomly assigned to early valve replacement or careful waiting with regular check-ups.
This study compares doing aortic valve replacement sooner versus waiting, in people with moderate aortic valve narrowing plus at least moderate leakage in the mitral valve. It aims to see which timing improves heart symptoms and outcomes while keeping treatment safe.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial compares two approaches for people with a leaking aortic valve but no symptoms: early surgery or careful monitoring (“watchful waiting”). It aims to see which strategy better prevents future heart problems and when surgery is most helpful.
This trial tests two types of replacement heart valves (self-expanding and balloon-expanding) in people who have severe aortic stenosis (tight heart valve) and an enlarged aorta (the main blood vessel from the heart). The goal is to see which valve type works better for these patients.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.